News|Articles|October 26, 2023
Overcoming Obstacles in Gene Therapy Manufacturing
Author(s)Resilience
When it comes to viral vectors, the complexities related to varying serotypes and different sized payloads continue to impact efficiencies and timelines. Hear from Resilience experts on how innovative platform technologies can overcome these challenges and support scalable manufacturing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
2
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
3
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
4
Streamlining Procurement and Inventory Management Leads to Increased Productivity
5
